Interestinggly, it seems to work better than Pluvicto for metastasis..."it showed median declines of -52%, -40%, -23% in visceral, bone, and nodal lesions, respectively."
225 AC PSMA J591 is active in mCRPC w... - Advanced Prostate...
225 AC PSMA J591 is active in mCRPC with difficult metastasis
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Excellent response to Ac-225-PSMA-617 in South Africa (update)
info based on new info on 73 treated patients. In 79% of patients, PSA declined by over 50%, and in...
Avoiding radiation damage to salivary glands with Ac-225-PSMA-617 therapy
important. Interesting caution about Chinese food....
Ac-225 results and next steps
mid-January to receive Ac-225 after Pluvicto failed. In spite of high PSMA uptake and no...
New radiopharmaceutical (Ac-225-PSMA-617) has high rates of remission in early trials
Ac-225-PSMA-617 is an alpha particle emitter that targets prostate cancer cells. Lu-177-PSMA-617 is...
Lu 177 along with AC 225
Anyone have experience with Ac-225 after Lu-177
Xofigo & Ac- 225 After failed Lu-177
Lu-177/Ac-225 and Liver Metastases
